Technology

Siemens Medical Solutions received FDA 510(k) clearance for a 1.5T magnetic resonance imaging (MRI) system that is ...

Home February 19, 2008
Home
News

February 19, 2008 - Boston Scientific Corp. closed the sale of its Fluid Management and Venous Access businesses to ...

Home February 18, 2008
Home
News

February 19, 2008 - A new study released today found pending congressional legislation seeking the mandatory disclosure ...

Home February 18, 2008
Home
News

February 19, 2008 - Among patients with acute myocardial infarction (AMI), prior statin therapy is associated with better perfusion after primary angioplasty of the infarct-related artery, according to a report in the January 15 issue of the American Journal of Cardiology.

Home February 18, 2008
Home
News

February 19, 2008 – The first CE certified Nobori Drug-Eluting Coronary Stent System was successfully implanted in Europe, as Terumo Corp. is poised to expand the product from spring 2008 to more than 20 countries in Europe, Asia, New Zealand and Africa.

Home February 18, 2008
Home
News

February 19, 2008 - A regimen of aspirin, clopidogrel and coumadin started at discharge decreased mortality and major adverse cardiac events (MACE) while keeping bleeding to acceptable levels in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with stent placement, reports a study in the February 26, 2008 issue of the Journal of the American College of Car

Home February 18, 2008
Home
News

February 19, 2008 – A novel, fully bioabsorbable salicylate-based stent offers the potential to reduce adverse events associated with current drug-eluting stents (DES) and could be very beneficial to patients with coronary heart disease, according to a presentation at the Cardiovascular Revascularization Therapies 2008 (CRT) symposium.

Home February 18, 2008
Home
News

February 19, 2008 – Clinicians implanted the BioMatrix drug-eluting stent system into the first European patients in a live broadcast during the Joint Interventional Meeting (JIM), held in Rome, Italy, from February 13-15. The BioMatrix drug-eluting stent system, by Biosensors International Group Ltd., combines a biodegradable PLA and the company’s proprietary limus drug, Biolimus A9.

Home February 18, 2008
Home
News

February 19, 2008 – The American College of Cardiology (ACC) urges the medical community to oppose cuts to medical ...

Home February 18, 2008
Home
News

February 18, 2008 - Abbott received FDA approval for SIMCOR a fixed-dose combination of two cholesterol therapies, Niaspan (Abbott’s proprietary niacin extended-release) and simvastatin, offering patients a new option for reaching healthy lipid levels.

Home February 17, 2008
Home
Technology

Siemens Healthcare will highlight the Magnetom Essenza which features 30 mT/m gradients, reportedly delivering excellent ...

Home February 17, 2008
Home
News

February 18, 2008 – OrbusNeich’s Genous Bio-engineered R stent is feasible and safe for use in acute myocardial infarction (AMI) patients, according to a paper published in the American Heart Journal (2008; Vol. 155, Issue 1: 128-132).

Home February 17, 2008
Home
News

February 18, 2008 - Treating patients who have occlusive femoropopliteal disease with paclitaxel-coated balloons during ...

Home February 17, 2008
Home
News

February 15, 2008 - Siemens received FDA 510(k) clearance for Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.

Home February 14, 2008
Home
News

February 15, 2008 - The Sorin Group is launching the Sorin MEMO 3D Annuloplasty Ring for mitral valve repair clinical ...

Home February 14, 2008
Home
Subscribe Now